Application
17048447 · Combination comprising HDAC inhibitor, LAG-3 inhibitor and a PD-1 inhibitor or PD-L1 inhibitor for cancer treatment
Filed 2020-10-16 · Abandoned The official file ↗ · Art unit 1628 · Examiner Yevgeny Valenrod Easy · CPC A61K 31/40 · 4SC AG · MILLEN, WHITE, ZELANO & BRANIGAN, P.C.
Office actions
2
first was Non-final rejection
RCEs
0
no appeal
To first action
39.3 mo
to disposition 52.9 mo
Statutes raised
103
2 actions read